|
Page 27
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 28
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
Page 29
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 30
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
The notes on pages 32 to 76 form part of these financial statements.
Page 31
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Heroes Technology Ltd (the "Company") is a private company limited by shares, incorporated in England and Wales under the Companies Act 2006. The Company's registered office is at Wisteria Grange Barn, Pikes End, Pinner, London, HA5 2EX. These consolidated financial statements comprise the Company and its subsidiaries (collectively the "Group" and individually "Group companies"). The Group is primarily involved in baby & juvenile products, and some other consumer products, across various geographies, predominantly through the Amazon marketplace platform and fulfilment network.
2.Accounting policies
The Group financial statements have been prepared in accordance with UK adopted international accounting standards. During the year, the parent company has changed its financial reporting framework from UK adopted International Accounting Standards to FRS 101. This has had no impact on the recognition, measurement or presentation of any amounts in the financial statements. The accounting policies have been applied consistently to all the years presented, unless otherwise stated. The preparation of financial statements in compliance with UK-adopted IFRS requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Group's accounting policies. The areas where significant judgements and estimates have been made in preparing the financial statements and their effect are disclosed in note 3. The Group's functional and presentational currency is GBP. Values are rounded to the nearest thousand pound, unless otherwise stated. The Company has taken advantage of the exemption available under section 408 of the Companies Act 2006 and elected not to present its individual Statement of Comprehensive Income and related notes. Additionally, no cash flow statement is presented as permitted by FRS 101.8 (h). Basis of measurement Where the Parent Company has control over an investee, it is classified as a subsidiary. The Parent Company controls an investee if all three of the following elements are present: power over the investee, exposure to variable returns from the investee, and the ability of the investor to use its power to affect those variable returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control. The consolidated financial statements present the results of the Parent Company and its subsidiaries (the "Group") as if they formed a single entity. Intercompany transactions and balances between group companies are therefore eliminated in full. The consolidated financial statements incorporate the results of business combinations using the acquisition method. In the Consolidated Statement of Financial Position, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the Consolidated Statement of Comprehensive Income from the date on which control is obtained. They are deconsolidated from the date on which control ceases.
Page 32
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
New standards, interpretations and amendments adopted from 1 January 2025
The following amendment became effective for accounting periods beginning on or after 1 January 2025:
∙Lack of Exchangeability (Amendments to IAS 21 – The Effects of Changes in Foreign Exchange Rates).
Management has assessed the impact of this amendment and concluded that it does not have a material effect on the Group’s or the Company’s financial statements.
New standards, interpretations and amendments not yet effective or endorsed
There are a number of standards, amendments to standards and interpretations issued by the IASB that are effective in future accounting periods and which the Group has not early adopted.
The following amendment is effective for annual reporting periods beginning on or after 1 January 2026:
∙Amendments to the Classification and Measurement of Financial Instruments (Amendments to IFRS 9 and IFRS 7).
The following new standards are effective for annual reporting periods beginning on or after 1 January 2027:
∙IFRS 18 – Presentation and Disclosure in Financial Statements.
∙IFRS 19 – Subsidiaries without Public Accountability: Disclosures.
The Group is currently assessing the impact of these new standards and amendments. Based on the assessment performed to date, the Group does not expect the adoption of the amendment to IFRS 9 and IFRS 7 to have a material impact on its financial statements. IFRS 18 is expected to affect the presentation and disclosure of information in the financial statements but is not expected to change the recognition or measurement of assets, liabilities, income or expenses. IFRS 19 is not expected to have a material impact as the Group does not currently anticipate applying the standard.
At the date of authorisation of these financial statements, certain standards and amendments issued by the IASB had not yet been endorsed for use in the UK by the UK Endorsement Board (UKEB). These standards have therefore not been applied in preparing these financial statements.
IFRS 18 – Presentation and Disclosure in Financial Statements, issued by the IASB in April 2024, is effective for annual reporting periods beginning on or after 1 January 2027 and will replace IAS 1 Presentation of Financial Statements. The standard introduces new requirements for the presentation and disclosure of information in the financial statements, including revised categories and subtotals in the statement of profit or loss, enhanced principles for aggregation and disaggregation of information, and disclosures relating to management-defined performance measures. The Group is currently assessing the impact of adopting IFRS 18. While the standard is not expected to affect the recognition or measurement of assets, liabilities, income or expenses, it is expected to result in changes to the presentation and disclosure of information in the Group’s financial statements.
IFRS 19 – Subsidiaries without Public Accountability: Disclosures is effective for annual reporting periods beginning on or after 1 January 2027. Based on the Group’s current structure and reporting requirements, the Group does not expect to be eligible to apply IFRS 19.
Page 33
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Debt facility details The Group has a senior debt facility of $150m (£111.5m), of which $109.8m (£86.6m) (2024: $92.8m (£74.1m)) was drawn at the reporting date. As disclosed in Note 18, in August 2025, the Group entered into an amendment letter to the senior credit facility agreement and released the Group from the net leverage and minimum liquidity covenants until the termination date. During the year and up to the date of approval of these financial statements, the directors have held discussions with the lender regarding the planned maturity of the facility and have obtained a facility extension to December 2027, as well as amendments to capitalise interest, to ensure the Group has sufficient liquidity to the maturity date. Downside scenarios and mitigating actions The directors have assessed potential downside scenarios and considered the mitigating actions available, including cost reductions and other measures to maintain sufficient liquidity. In addition, the Group’s senior lender, who is also the majority shareholder, has confirmed their current intention to work constructively with the Group to provide support including waivers, amendments, or other accommodations if required. Material uncertainty The Group's senior debt facility is contractually due for repayment in December 2027. Although covenant waivers and facility extensions have been granted previously, there is no formal agreement in place for the lender to renew, extend, or refinance the loan beyond its contractual maturity date. The Group does not currently have sufficient cash resources to settle the loan in full at the repayment date, and at the date of approval of these financial statements, no alternative committed refinancing arrangements have been secured. Directors’ expectation
Page 34
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Key factors considered In reaching this conclusion, the directors have considered: Conclusion Based on this review, the directors are satisfied that it is appropriate to prepare the financial statements on a going concern basis. Notwithstanding the material uncertainty that exists, the Board’s confidence in the following factors supports this assessment:
Revenue is measured based on the consideration specified in a contract with a customer and excludes amounts collected on behalf of third parties. The Group recognises revenue when it transfers control over a product to a customer.
The Group does not expect to have any contracts where the period between the transfer of the promised goods to the customer and payment by the customer exceeds one year. As a consequence, the Group does not adjust any of the transaction prices for the time value of money. Principal versus agent When another party is involved in providing goods to a customer, the Group determines whether the nature of its promise is a performance obligation to provide the specified goods itself (i.e. the Group is a principal) or to arrange for those goods to be provided by the other party (i.e. the Group is an agent). The Group is a principal if it controls the specified good before that good or service is transferred to a customer. The Group is an agent if its performance obligation is to arrange for the provision of the specified good, delivery and wrapping service by another party. In this case, the Group does not control the specified good, delivery and wrapping service provided by another party before that good is transferred to the customer. When the Group acts as an agent, it recognises revenue at the net amount to which it expects to be entitled in exchange for arranging for the specified good, delivery and wrapping service to be provided by the other party.
Page 35
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Items included in the financial statements of each of the Group's entities are measured using the currency of the primary economic environment in which the entity operates (the functional currency). The Parent Company's functional currency and the Group's presentational currency is Sterling. Transactions and balances Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at the reporting period end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss. On consolidation, the results of overseas operations are translated into Sterling at rates approximating to those ruling when the transactions took place. All assets and liabilities of overseas operations, including goodwill arising on the acquisition of those operations, are translated at the rate ruling at the reporting date. Exchange differences arising on translating the opening net assets at opening rate and the results of overseas operations at actual rate are recognised in other comprehensive income and accumulated in the foreign exchange reserve. On disposal of a foreign operation, the cumulative exchange differences recognised in the foreign exchange reserve relating to that operation up to the date of disposal are transferred to profit or loss as part of the profit or loss on disposal.
Finance costs comprise interest expenses that relate to a shareholder loan and bank borrowings, and amortisation of finance costs. Finance income comprises interest income that relates to bank deposits and net changes in fair value of derivative financial instruments. Interest expenses and income are accounted for on an accruals basis in profit or loss.
The Group operates a defined contribution pension scheme. Contributions to the scheme are charged to profit or loss in the period to which they relate. Amounts not paid are shown in accruals as a liability in the Consolidated Statement of Financial Position.
Page 36
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
The total expense to be apportioned over the vesting period of the benefit is determined by reference to the fair value (excluding the effect of non-market-based vesting conditions) at the date of grant. At the end of each reporting period the assumptions underlying the number of awards expected to vest are adjusted for the effects of non-market-based vesting conditions to reflect the conditions prevailing at that date. The impact of any revisions to the original estimates is recognised in the statement of profit or loss, with a corresponding adjustment to equity. Fair value is measured by the use of the Black-Scholes pricing model. The expected life used in the model has been adjusted, based on management's best estimate, for the effects of non-transferability, exercise restrictions and behavioural considerations. When share options are exercised, the Company issues new shares. The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Group operates and generates income.
Page 37
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
The amount of the asset or liability is determined using tax rates that have been enacted or substantively enacted by the reporting date and are expected to apply when the deferred tax liabilities/(assets) are settled/(recovered). Deferred tax assets and liabilities are offset when the Group has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority on either:
Depreciation is provided on all other items of property, plant and equipment so as to write off their carrying value over their expected useful economic lives. It is provided at the following rates:
Page 38
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
For the purposes of impairment testing, goodwill is allocated to each of the Group's cash-generating units (or groups of cash-generating units) that is expected to benefit from the synergies of the combination. A cash-generating unit to which goodwill has been allocated is tested for impairment annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than its carrying amount, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro rata based on the carrying amount of each asset in the unit. Any impairment loss for goodwill is recognised directly in profit or loss. An impairment loss recognised for goodwill is not reversed in subsequent periods. On disposal of the relevant cash-generating unit, the attributable amount of goodwill is included in the determination of the profit or loss on disposal. Where it is not possible to estimate the recoverable amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there are separately identifiable cash flows; its cash-generating units ("CGUs"). Goodwill is allocated on initial recognition to each of the Group's CGUs that are expected to benefit from a business combination that gives rise to the goodwill. Impairment charges are included in profit or loss. An impairment loss recognised for goodwill is not reversed.
Page 39
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Derivatives embedded in non-derivative host contracts that are not financial assets within the scope of IFRS 9 (e.g. financial liabilities) are treated as separate derivatives when they meet the definition of a derivative, their risks and characteristics are not closely related to those of the host contracts and the host contracts are not measured at FVTPL. Derivatives embedded in hybrid contracts that contain financial asset hosts within the scope of IFRS 9 are not separated. The entire hybrid contract is classified and subsequently measured at either amortised cost or FVTPL as appropriate.
Financial assets and financial liabilities are recognised in the Statement of Financial Position when the Group becomes a party to the contractual provisions of the instrument.
Financial assets
Investments other than investments in subsidiaries are classified as either held-for-trading or not at initial recognition. At the year-end date all investments are classified as not held for trading.
Trade receivables are held in order to collect the contractual cash flows and are initially measured at the transaction price as defined in IFRS 15, as the contracts of the Group do not contain significant financing components. Impairment losses are recognised based on lifetime expected credit losses in profit or loss.
Other receivables are held in order to collect the contractual cash flows and accordingly are measured at initial recognition at fair value, which ordinarily equates to cost and are subsequently measured at cost less impairment due to their short-term nature. A provision for impairment is established based on 12 month expected credit losses unless there has been a significant increase in credit risk when lifetime expected credit losses are recognised. The amount of any provision is recognised in profit or loss.
Cash and cash equivalents comprise cash held by the Group and short-term bank deposits with an original maturity of three months or less.
The Group derecognises a financial asset only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another entity.
Page 40
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Financial instruments (continued)
Financial liabilities and equity
Financial liabilities and equity instruments issued by the Group are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the Group after deducting all of its liabilities. Equity instruments issued by the Group are recorded at the proceeds received, net of direct issue costs.
Interest bearing loans and advanced share subscriptions are initially recorded at fair value, which is ordinarily equal to the proceeds received net of transaction costs. These liabilities are subsequently measured at amortised cost, using the effective interest rate method.
The Group had issued warrants to a warrant-holder in connection with a loan facility granted to the Group. The warrants could have subscribed for a variable number of ordinary shares of the Group, and it was being treated as an embedded derivative. All warrants were exercised during 2024. An embedded derivative is a component of a hybrid contract that also includes a non-derivative host with the effect that some of the cash flows of the combined instrument vary in a way similar to a stand-alone derivative.
Derivatives embedded in hybrid contracts with hosts that are financial liabilities are treated as separate derivatives when they meet the definition of a derivative, their risks and characteristics are not closely related to those of the host contracts, and the host contracts are not measured at FVTPL. An embedded derivative is recognised initially at fair value at the date a derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. An embedded derivative is presented as a non-current liability if the remaining maturity of the hybrid instrument to which the embedded derivative relates is more than 12 months and is not expected to be realised or settled within 12 months.
The Group derecognises financial liabilities when, and only when, the Group's obligations are discharged, cancelled or have expired. The difference between the carrying amount of the financial liability derecognised and the consideration paid and payable is recognised in profit or loss.
Page 41
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
The right-of-use asset has been measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Group, an estimate of any costs to dismantle and remove the asset at the end of the lease, and any lease payments made in advance of the lease commencement date. The Group depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. Where impairment indicators exist, the right-of-use asset will be assessed for impairment. The lease liabilities are measured at the present value of the lease payments due to the lessor over the lease term, discounted using the interest rate implicit in the lease. If that rate is readily available or the Group's incremental borrowing rate if not. After initial measurement, any payments made will reduce the liability and the interest accrued will increase it. On the Statement of Financial Position, right-of-use assets have been included in property, plant and equipment.
Page 42
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
In applying the Group's accounting policies, which are described in note 2, the directors are required to make judgements (other than those involving estimations) that have a significant impact on the amounts recognised and to make estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. Judgements The following is the critical judgement apart from those involving estimations (which are presented separately below), that the directors have made in the process of applying the Group's accounting policies and that have the most significant effect on the amounts recognised in financial statements. Principal versus agent consideration
The Group is considered as an agent for some of its contracts with customers relating to selling products through Amazon marketplace. This is because the Group does not obtain the control over the products and does not carry out delivery and wrapping service before passing the product on to customers. The Group considers the indicators of acting as an agent in this instance, for example the Group not being primarily responsible for fulfilling the promise of the goods and not establishing the price of delivery or wrapping the products. When the Group satisfies the performance obligation, the Group recognises net revenue being the amount it expects to be entitled to as specified in the contracts.
Estimates and assumptions The key assumptions concerning the future, and other key sources of estimation uncertainty at the reporting period that may have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are discussed below.
Valuation of acquired intangibles
Management identified and valued acquired intangible assets on acquisitions that were made during the prior period. Management has applied judgement in identifying and valuing intangible assets separate from goodwill that consist of assessing the value of trademarks, contracts, business relationships and other intangible assets. The Group consistently applies the methodologies in calculating intangible asset values in each acquisition. There are a number of assumptions in estimating the present value of future cash flows including management's expectation of future revenue, gross margin percentage and discount rates.
Assumptions are made on the useful life of an intangible and if shortened, would increase the amortisation charge recognised in profit or loss. The identified intangibles are set out in note 12.
Page 43
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Accounting estimates and judgements (continued) Estimates and assumptions (continued) Impairment of intangible assets and goodwill
At each reporting date, management perform impairment assessments by estimating the recoverable amount of each asset or cash generating unit based on expected future cash flows and uses an interest rate to discount them. Estimation uncertainty relates to assumptions about future operating results and the determination of a suitable discount rate. In the year ended 31 December 2025, the Group recognised an impairment loss on Internally generated software development costs, Trademarks, brand and assumed contracts and Goodwill. See note 12 & 13.
Valuation of inventories
Management estimates the net realisable values of inventories, taking into account the most evidence available at each reporting date. The future realisation of these inventories may be affected by other market-driven changes or future technology that may reduce future selling prices.
Fair value measurement
Management uses various valuation techniques to determine the fair value of financial instruments (where active market quotes are not available). This involves developing estimates and assumptions consistent with how market participants would price the instrument. Management bases its assumptions on observable data as far as possible, but this is not always available. In that case, management uses the best information available. Estimated fair values may vary from the actual prices that would be achieved in an arm's length transaction at the reporting date, see note 19 & 24.1.
Useful life of trademark
Management reviews the estimate of the useful life of trademarks at each reporting date, based on the expected utility of the trademark. Uncertainties in these estimates relate to the forecast of demands of products and the changes in market.
The uncertainties described above in respect of the potential impairment of goodwill in the Group financial statements also represent uncertainties regarding the carrying value of the investment in subsidiaries in the Company financial statements. As at 31 December 2025 the carrying value of this investment was £34,171k (2024 - £34,171k).
Page 44
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 45
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 46
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 47
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 48
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 49
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
10.Tax expense/(credit) (continued)
Changes in tax rates and factors affecting the future tax charges
The company expects its future profits to be subject to corporation tax at the main rate of 25%, based on current legislation.
There are currently no other material enacted or substantively enacted changes in tax law or rates which are expected to materially impact the company's future current or deferred tax charges.
Page 50
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
10.Tax expense/(credit) (continued)
Page 51
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 52
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 53
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 54
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Impairment charges have been recognised for goodwill and trademarks where the value in use of the CGU is less than the carrying value. Impairment charges have been recognised for the following CGUs:
At 31 December 2025, the reversal of impairment of goodwill and trademarks was £1,397k on the CGUs identified with impairment. If the discount rate for the CGUs was increased by 3%, goodwill would remain the same and a further impairment loss of £1,583k would be recognised on trademarks. If sales growth was reduced by 3%, a further impairment loss of £5,381k would be recognised. These impairment losses would be split between goodwill and trademarks.
Impairment of goodwill of £Nil (2024 - £1,578k) was recognised and included under other expenses in the Consolidated Statement of Comprehensive Income. None of the goodwill is expected to be tax deductible.
Page 55
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 56
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 57
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
14.Subsidiaries (continued)
Acquistion of iL Tutto
On 6 February 2025, the Group acquired 100% of iL Tutto through its subsidiary, Heroes Australia Pty Ltd. iL Tutto is an Australian company specialising in premium nursery furniture, including cots, nursing chairs and bassinets, complementing the Group’s existing product offering in the baby and child sector. Under the executed Share Purchase Agreement, the total consideration transferred was AUD 12.1 million. The consideration comprised the closing payment and contingent consideration of AUD 2.9 million. The acquisition has been accounted for as a business combination using the acquisition method. The following table summarises the allocation of the consideration transferred to the assets acquired and liabilities assumed at their acquisition-date fair values:
Page 58
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Acquistion of iL Tutto (continued) The iL Tutto brand was identified as a separately recognisable intangible asset and was valued at AUD 10.2 million (£5.1 million). The valuation was determined using the multi-period excess earnings method, with the relief-from-royalty method used as a cross-check. Goodwill of AUD 2.9 million (£1.5 million) was recognised, including the value attributed to the assembled workforce. The goodwill primarily reflects the expected benefits from extending the iL Tutto brand into new markets, including Amazon, and synergies arising from combining iL Tutto’s product ranges and management capabilities with those of the Group. Acquisition-related costs amounted to £0.4m. From the acquisition date to 31 December 2025, the iL Tutto brand contributed £11.2m of net revenue and £2.2m of net profit to the Group.
Page 59
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 60
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 61
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 62
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
18.Loans and borrowings (continued)
Page 63
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 64
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 65
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Share capital (continued) On 28 March 2024, the Company issued 318,966 Series A shares with a nominal value of £0.000001 per share for consideration of £15.19 per share. Share premium of £4,841,000 was recognised as a result. This share issue was due to conversion of Advanced Subscription Agreements. Between 4 June 2024 and 1 July 2024, the Company issued the following shares;
∙110,538 Ordinary shares with a nominal value of £0.000001 for consideration of £0.000001 per share.
∙62,588 Ordinary shares with a nominal value of £0.000001 for consideration of £0.0085 per share. Share premium of £532 was recognised as a result.
∙5,874 Ordinary shares with a nominal value of £0.000001 for consideration of £0.0087 per share. Share premium of £51 was recognised as a result.
∙20,378 Ordinary shares with a nominal value of £0.000001 for consideration of £0.0097 per share. Share premium of £198 was recognised as a result.
∙53 Ordinary shares with a nominal value of £0.000001 for consideration of £4.57 per share. Share premium of £242 was recognised as a result.
On 31 October 2024, the Company's "A Ordinary" and "Series A" shares were re-designed as "Ordinary" shares.
Page 66
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Share premium reserve
Share option reserve
Foreign currencies translation reserve
Retained earnings/accumulated deficit
Page 67
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 68
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 69
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 70
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
24.Financial instruments - fair values and risk management (continued)
Page 71
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
24.Financial instruments - fair values and risk management (continued)
The Group's objectives when managing capital are to safeguard the Group's ability to continue as a going concern in order to provide returns for shareholders and maintain an optimal capital structure to reduce the cost of capital.
The Group defines capital as being share capital plus all reserves, which amounted to a deficit of £41,339k as at 31 December 2025 (2024 - £30,321k). The board of directors monitors the level of capital as compared to the Group's long term debt commitments and adjusts the ratio of debt to capital as is determined to be necessary, by issuing new shares, reducing or increasing debt, paying dividends and returning capital to shareholders. The Group is subject to externally imposed capital requirements in the form of a net leverage ratio covenant imposed by a lender, as set out in note 18.
Page 72
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
24.Financial instruments - fair values and risk management (continued)
The Group's assets exposed to credit risk are primarily attributable to its cash and cash equivalents and trade receivables. The maximum exposure of such assets to credit risk is their carrying amounts as of the reporting date. As of 31 December 2025, 97% (2024 - 97%) of the Group's cash and cash equivalents were held by multi-national financial institutions with an AA3 credit rating. Management monitors the credit risk of financial institutions based on publicly available information. Trade receivables are mainly derived from sales to customers through Amazon and well-established retailers. Management considers the credit risk of trade receivables is minimal.
Page 73
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
The Company has taken advantage of the exemption in IAS 24 to not disclose transactions with wholly owned Group entities.
During the period the Group paid salaries to other related parties (domestic partners of key management personnel) totalling £123k (2024 - £235k).
As at year end, the controlling party of Heroes Technology Limited is Crayhill Capital GenPar LLC.
On 3 July 2024 HTL Holdco Limited acquired 100% of the Company's share capital because of a restructuring in the group. HTL Holdco Limited is therefore the Company's immediate parent at 31 December 2025. HTL Holdco Limited's registered office is Suite 1, 7th Floor 50 Broadway, London, United Kingdom, SW1H 0DB.
Page 74
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Senior facility amendments
Following the year end, the Group agreed further amendments to its senior lending facilities. These amendments included the capitalisation of interest for a defined period, and an extension of maturity. The revised terms provide additional financial flexibility and support the Group’s liquidity position. Please see borrowings above for further details. Shopify revenue-based financing facility In March 2026, the Group entered into a revenue-based financing arrangement with Shopify Capital in the amount of USD 250k. The facility was drawn to support short-term working capital requirements and is repaid through a fixed percentage of daily sales. The financing was entered into following a review of available funding options provided by Shopify Capital and forms part of the Group’s broader liquidity management framework, which includes the use of short-term, flexible financing instruments linked to trading performance. The Group continues to monitor its liquidity position on an ongoing basis and considers access to revenue-based financing as an ancillary funding source to support working capital fluctuations. The facility does not include financial covenants; however, repayment is inherently linked to future sales performance, which may result in variability in cash outflows over time. Additional borrowings The Group utilised a Flexport working capital facility, shared across several segments. The facility provides a maximum exposure of USD 2.5m and is structured as a short-term working capital solution linked to trade payables and receivables timing. The facility carries an effective cost of approximately 12% (comprising a 3.15% charge per 90-day period and a 15bps monitoring fee). From July 2026, the facility is expected to be reduced in stages from USD 2.5m to USD 1.5m. At the same time, the repayment structure is expected to transition from a 90-day full repayment model to a combined 45-90-day repayment structure. Utilisation varies depending on payment terms (typically 45–90 days) and the timing of new invoice generation, and therefore fluctuates in line with working capital movements across the Group. The arrangement forms part of the Group’s broader working capital financing framework. US tariff claim Subsequent to the reporting date, developments relating to US tariff regulations resulted in a reimbursement of previously incurred tariff charges. USD 2.1m plus interest, recognised in June 2026. Minnesota Warehouse The Group completed the transition of its Minnesota warehouse operations to a third-party logistics provider, successfully transferring inventory and fulfilment activities without significant operational disruption.
Page 75
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HEROES TECHNOLOGY LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Subsequent events (continued) Changes in the composition of the Management Board
∙Neil Sharma-Burford (Executive Director) resigned on 5 February 2026.
∙Duncan Miller (Executive Director) was appointed on 4 February 2026.
∙Alessio Bruni resigned from his position as Chief Operating Officer on 1 March 2026.
∙Giancarlo Bruni resigned from his position as Chief Financial Officer on 1 March 2026.
∙Riccardo Bruni resigned from his position as Chief Information Officer on 1 March 2026.
In preparing its individual financial statements under FRS 101, the Company has taken advantage of the following disclosure exemptions permitted by FRS 101:
∙the requirements of IFRS 7 Financial Instruments: Disclosures
∙the requirements of paragraphs 91 to 99 of IFRS 13 Fair Value Measurement
∙the requirements of the second sentence of paragraph 110 and paragraphs 113(a), 114, 115, 118, 119(a) to (c), 120 to 127 and 129 of IFRS 15 Revenue from Contracts with Customers
∙the requirements in paragraph 38 of IAS 1 Presentation of Financial Statements to present comparative information in respect of:
- paragraph 79(a)(iv) of IAS 1
- paragraph 73(e) of IAS 16 Property, Plant and Equipment
- paragraph 118(e) of IAS 38 Intangible Assets
∙the requirements of paragraphs 10(d), 10(f), 16, 38A, 38B, 38C, 38D, 40A, 40B, 40C, 40D, 111 and 134-136 of IAS 1 Presentation of Financial Statements
∙the requirements of IAS 7 Statement of Cash Flows
∙the requirements of paragraphs 30 and 31 of IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors
∙the requirements of paragraph 74A(b) of IAS 16
∙the requirements of paragraphs 17 and 18A of IAS 24 Related Party Disclosures
∙the requirements in IAS 24 Related Party Disclosures to disclose related party transactions entered into two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly owned by such a member
∙the requirements of paragraphs 130(f)(ii), 130(f)(iii), 134(d) to 134(f) and 135(c) to 135(e) of IAS 36 Impairment of Assets
Page 76
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||